Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:22734004  

Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration.

Jamie L Marshall | Johan Holmberg | Eric Chou | Amber C Ocampo | Jennifer Oh | Joy Lee | Angela K Peter | Paul T Martin | Rachelle H Crosbie-Watson
The Journal of cell biology | 2012

Utrophin is normally confined to the neuromuscular junction (NMJ) in adult muscle and partially compensates for the loss of dystrophin in mdx mice. We show that Akt signaling and utrophin levels were diminished in sarcospan (SSPN)-deficient muscle. By creating several transgenic and knockout mice, we demonstrate that SSPN regulates Akt signaling to control utrophin expression. SSPN determined α-dystroglycan (α-DG) glycosylation by affecting levels of the NMJ-specific glycosyltransferase Galgt2. After cardiotoxin (CTX) injury, regenerating myofibers express utrophin and Galgt2-modified α-DG around the sarcolemma. SSPN-null mice displayed delayed differentiation after CTX injury caused by loss of utrophin and Akt signaling. Treatment of SSPN-null mice with viral Akt increased utrophin and restored muscle repair after injury, revealing an important role for the SSPN-Akt-utrophin signaling axis in regeneration. SSPN improved cell surface expression of utrophin by increasing transportation of utrophin and DG from endoplasmic reticulum/Golgi membranes. Our experiments reveal functions of utrophin in regeneration and new pathways that regulate utrophin expression at the cell surface.

Pubmed ID: 22734004

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR048179
  • Agency: NIGMS NIH HHS, United States
    Id: GM07104
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM065823
  • Agency: NIA NIH HHS, United States
    Id: R01 AG047922
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007104
  • Agency: NIAMS NIH HHS, United States
    Id: P30 AR057230
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR047922
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM65823
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR049722

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.